SOUTH SAN FRANCISCO, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Corgentech Inc. , a biotechnology company, today announced that John P. McLaughlin, the company’s chief executive officer, will present at the 2006 BIO CEO and Investor Conference on February 15, 2006 at 11:00 a.m. EST in New York City. Mr. McLaughlin will discuss the company’s pipeline of pain management and inflammation product candidates and will review the company’s projected milestones for 2006.
To access the live webcast or the subsequent archived recording, log on to www.corgentech.com and go to the Investors page, and click on Webcasts. Please connect to Corgentech’s website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
About Corgentech
Corgentech is a late-stage biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for pain management and inflammation. Corgentech is based in South San Francisco, CA. For more information on the company, please visit www.corgentech.com.
Corgentech Inc.
CONTACT: Jennifer Cook Williams, Senior Director, Investor Relations ofCorgentech Inc., +1-650-624-9600, or investors@corgentech.com
Web site: http://www.corgentech.com/
